share

5,6,7,9,10,14B-Hexahydro-5-Methylisoquino[2,1-D][1,4]Benzodiazepine CAS NO 19007-31-9


Unit Price:

CAS No.:19007-31-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

5,6,7,9,10,14B-Hexahydro-5-Methylisoquino[2,1-D][1,4]Benzodiazepine is a complex, polycyclic organic compound belonging to the benzodiazepine class, serving as a crucial advanced intermediate in modern synthetic chemistry. Its intricate fused-ring structure makes it a valuable building block for the research and development of novel pharmaceutical agents and bioactive molecules. This high-purity compound is primarily sought by research institutions and pharmaceutical developers working on central nervous system (CNS) targets, chemical synthesis, and process optimization.

Application

  • Pharmaceutical Intermediate: A key synthetic precursor in the research and development of novel benzodiazepine-derived therapeutic agents.
  • Chemical Research & Development: Used as a sophisticated building block for constructing complex polycyclic molecular architectures in academic and industrial R&D settings.
  • Bioactive Molecule Synthesis: Employed in the synthesis of compounds for biological screening and pharmacological studies targeting specific receptors.
  • Process Chemistry: Serves as a critical intermediate for scaling up synthetic routes and optimizing manufacturing processes for active pharmaceutical ingredients (APIs).
  • Reference Standard: Can be utilized as a high-purity analytical standard for method development and quality control in related chemical production.

Basic Information

Product Name 5,6,7,9,10,14B-Hexahydro-5-Methylisoquino[2,1-D][1,4]Benzodiazepine
CAS No. 19007-31-9
Molecular Formula C₁₈H₂₀N₂
Molecular Weight 264.37 g/mol
Synonyms 5-Methyl-5,6,7,9,10,14b-hexahydroisoquino[2,1-d][1,4]benzodiazepine; 5-Methyl-5,6,7,9,10,14b-hexahydroisoquino[2,1-d][1,4]benzodiazepine; Isoquino[2,1-d][1,4]benzodiazepine, 5,6,7,9,10,14b-hexahydro-5-methyl-; 5-Methyl-5,6,7,9,10,14b-hexahydroisoquinolino[2,1-d][1,4]benzodiazepine
EINECS Contact for details

Quality Control

Our 5,6,7,9,10,14B-Hexahydro-5-Methylisoquino[2,1-D][1,4]Benzodiazepine is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including chromatographic purity assays and structural confirmation. A Certificate of Analysis (COA) detailing specific results is provided with every shipment to support your quality assurance and regulatory needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials and sources of ignition.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 98.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.